Secondary HLH is uncommon in severe COVID-19

Br J Haematol. 2020 Sep;190(5):e283-e285. doi: 10.1111/bjh.16934. Epub 2020 Aug 10.

Henry Wood^{1

2}, John R Jones¹, Kit Hui³, Tracey Mare³, Tasneem Pirani⁴, James Galloway^{2

5}, Victoria Metaxa⁴, Reuben Benjamin^{1

2}, Andrew Rutherford⁵, Sharon Cain⁴, Austin G Kulasekararaj^{1

2

6}

¹ Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK.
² King's College London, London, UK.
³ Viapath, King's College Hospital NHS Foundation Trust, London, UK.
⁴ Department of Critical Care, King's College Hospital NHS Foundation Trust, London, UK.
⁵ Department of Rheumatology, King's College Hospital NHS Foundation Trust, London, UK.
⁶ NIHR/Wellcome King's Clinical Research Facility, London, UK.

No abstract available

Keywords: COVID-19; HLH; SARS-CoV-2; cytokine; leucoerythroblastic; secondary haemophagocytic lymphohistiocytosis.

Publication types